Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aggressive Antipyretics in CNS Malaria
NCT03399318Phase 2Completed
- Sponsor
- University of Rochester
- Start
- Jan 2019
- Primary completion
- Dec 2022
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of acetaminophen, ibuprofen in cerebral malaria (CM), sponsored by University of Rochester. Started Jan 2019; status: completed.
02
Drugs
acetaminophenibuprofen
03
Conditions
cerebral malaria (CM)
Beyond the preview
Go deeper on NCT03399318.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03399318.